These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 32059540)

  • 21. Authorization of Animal Experiments Is Based on Confidence Rather than Evidence of Scientific Rigor.
    Vogt L; Reichlin TS; Nathues C; Würbel H
    PLoS Biol; 2016 Dec; 14(12):e2000598. PubMed ID: 27911892
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Harm-Benefit Analyses Can Be Harmful.
    Niemi SM
    ILAR J; 2021 Sep; 60(3):341-346. PubMed ID: 32785593
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ethical Considerations in Mouse Experiments.
    Baertschi B; Gyger M
    Curr Protoc Mouse Biol; 2011 Mar; 1(1):155-67. PubMed ID: 26068990
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preventing harm in resuscitation medicine.
    Ardagh M
    N Z Med J; 1997 Apr; 110(1041):113-5. PubMed ID: 9140410
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Justifiability and Animal Research in Health: Can Democratisation Help Resolve Difficulties?
    Khoo SY
    Animals (Basel); 2018 Feb; 8(2):. PubMed ID: 29443894
    [TBL] [Abstract][Full Text] [Related]  

  • 26. American Society of Clinical Oncology policy statement: oversight of clinical research.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2377-86. PubMed ID: 12721281
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reevaluating Benefits in the Moral Justification of Animal Research: A Comment on "Necessary Conditions for Morally Responsible Animal Research".
    Eggel M; Neuhaus CP; Grimm H
    Camb Q Healthc Ethics; 2020 Jan; 29(1):131-143. PubMed ID: 31858941
    [TBL] [Abstract][Full Text] [Related]  

  • 28. How to develop cost-conscious guidelines.
    Eccles M; Mason J
    Health Technol Assess; 2001; 5(16):1-69. PubMed ID: 11427188
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Consideration and checkboxes: incorporating ethics and science into the 3Rs.
    Landi MS; Shriver AJ; Mueller A
    J Am Assoc Lab Anim Sci; 2015 Mar; 54(2):224-30. PubMed ID: 25836970
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Scientific uses of animals: harm-benefit analysis and complementary approaches to implementing the three Rs.
    Griffin G; Clark JM; Zurlo J; Ritskes-Hoitinga M
    Rev Sci Tech; 2014 Apr; 33(1):265-72. PubMed ID: 25000799
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Communication of potential benefits and harm to patients and payers in psychiatry: a review and commentary.
    Wu R; Kemp DE; Sajatovic M; Zhao J; Calabrese JR; Gao K
    Clin Ther; 2011 Dec; 33(12):B62-76. PubMed ID: 22177380
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alternatives to animal experimentation in basic research.
    Gruber FP; Hartung T
    ALTEX; 2004; 21 Suppl 1():3-31. PubMed ID: 15586255
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bias During the Evaluation of Animal Studies?
    Knight A
    Animals (Basel); 2012 Feb; 2(1):85-92. PubMed ID: 26486779
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Does the goal justify the methods? Harm and benefit in neuroscience research using animals.
    Vieira de Castro AC; Olsson IA
    Curr Top Behav Neurosci; 2015; 19():47-78. PubMed ID: 24844681
    [TBL] [Abstract][Full Text] [Related]  

  • 35. No. 385-Indications for Pelvic Examination.
    Evans D; Goldstein S; Loewy A; Altman AD
    J Obstet Gynaecol Can; 2019 Aug; 41(8):1221-1234. PubMed ID: 31331610
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Researchers' attitudes to the 3Rs-An upturned hierarchy?
    Franco NH; Sandøe P; Olsson IAS
    PLoS One; 2018; 13(8):e0200895. PubMed ID: 30110335
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Public Health Interventions with Harms and Benefits: A Graphical Framework for Evaluating Tradeoffs.
    Pitt AL; Goldhaber-Fiebert JD; Brandeau ML
    Med Decis Making; 2020 Nov; 40(8):978-989. PubMed ID: 32996356
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.